CO6331461A2 - Proceso de preparacion de derivados del acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico - Google Patents

Proceso de preparacion de derivados del acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico

Info

Publication number
CO6331461A2
CO6331461A2 CO10143043A CO10143043A CO6331461A2 CO 6331461 A2 CO6331461 A2 CO 6331461A2 CO 10143043 A CO10143043 A CO 10143043A CO 10143043 A CO10143043 A CO 10143043A CO 6331461 A2 CO6331461 A2 CO 6331461A2
Authority
CO
Colombia
Prior art keywords
halobifenil
ciclopropanocarboxilico
preparation process
acid derivatives
derivatives preparation
Prior art date
Application number
CO10143043A
Other languages
English (en)
Spanish (es)
Inventor
Benoit Folleas
Hubert Botte
Fausto Pivetti
Thomas Delacroix
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of CO6331461A2 publication Critical patent/CO6331461A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/14—Preparation of carboxylic acid nitriles by reaction of cyanides with halogen-containing compounds with replacement of halogen atoms by cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO10143043A 2008-06-11 2010-11-16 Proceso de preparacion de derivados del acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico CO6331461A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08158022A EP2133322A1 (en) 2008-06-11 2008-06-11 Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid

Publications (1)

Publication Number Publication Date
CO6331461A2 true CO6331461A2 (es) 2011-10-20

Family

ID=40120119

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10143043A CO6331461A2 (es) 2008-06-11 2010-11-16 Proceso de preparacion de derivados del acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico

Country Status (27)

Country Link
US (1) US8076505B2 (enExample)
EP (2) EP2133322A1 (enExample)
JP (1) JP5642067B2 (enExample)
KR (1) KR101257217B1 (enExample)
CN (1) CN102046576B (enExample)
AT (1) ATE552230T1 (enExample)
AU (1) AU2009256959B2 (enExample)
BR (1) BRPI0909560A2 (enExample)
CA (1) CA2723878C (enExample)
CO (1) CO6331461A2 (enExample)
DK (1) DK2285765T3 (enExample)
ES (1) ES2384368T3 (enExample)
GE (1) GEP20135800B (enExample)
HR (1) HRP20120517T1 (enExample)
IL (1) IL209209A (enExample)
MA (1) MA32297B1 (enExample)
ME (1) ME01160B (enExample)
MX (1) MX2010012285A (enExample)
MY (1) MY150280A (enExample)
NZ (1) NZ589087A (enExample)
PL (1) PL2285765T3 (enExample)
PT (1) PT2285765E (enExample)
RU (1) RU2502721C2 (enExample)
SI (1) SI2285765T1 (enExample)
UA (1) UA101835C2 (enExample)
WO (1) WO2009149797A1 (enExample)
ZA (1) ZA201007977B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE409176T1 (de) * 2003-02-21 2008-10-15 Chiesi Farma Spa 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
CN102596879B (zh) * 2009-08-04 2015-01-28 奇斯药制品公司 制备1-(2-卤代联苯-4-基)-环丙烷羧酸的衍生物的方法
KR20130036210A (ko) * 2010-04-01 2013-04-11 키에시 파르마슈티시 엣스. 피. 에이. 신규 다형체 및 염
ES2526522T3 (es) * 2010-04-21 2015-01-13 Chiesi Farmaceutici S.P.A. Derivados del ácido 1-(2-fluorobifenil-4-il)alquil carboxílico para la terapia de la amiloidosis transtiretina
CN102905701A (zh) 2010-06-04 2013-01-30 奇斯药制品公司 用于治疗朊病毒病的1-(2-氟联苯-4-基)-环丙烷羧酸衍生物
US9592210B2 (en) 2011-12-22 2017-03-14 Chiesi Farmaceutici S.P.A. 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment
EP2834214A1 (en) 2012-04-04 2015-02-11 Chiesi Farmaceutici S.p.A. Derivatives of 1-(2-halo-biphenyl-4-yl)- alkanecarboxylic acids for the treatment of neurodegenerative diseases
EP2818460A1 (en) 2013-06-24 2014-12-31 ZaCh System S.p.A. Cyclopropanation of substituted phenylacetonitriles or phenyl acetates
CA2915773A1 (en) 2013-06-24 2014-12-31 Chiesi Farmaceutici S.P.A. Improved process for the preparation of derivatives of 1-(2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid
WO2015181094A1 (en) 2014-05-26 2015-12-03 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome
CN107698462A (zh) * 2017-10-10 2018-02-16 重庆科脉生物化工有限公司 一种1‑氨基‑1‑环丙腈盐酸盐的制备方法
AU2022338032A1 (en) 2021-08-31 2024-03-07 Cerespir Incorporated Co-crystals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4507294B2 (ja) * 1999-05-27 2010-07-21 チッソ株式会社 ビアリール誘導体の製造方法
JP4502293B2 (ja) * 1999-06-04 2010-07-14 長瀬産業株式会社 軸不斉を有する光学活性な４級アンモニウム塩、その製法およびα−アミノ酸誘導体の不斉合成への応用
JP2004091342A (ja) * 2002-08-29 2004-03-25 Matsushita Electric Ind Co Ltd 芳香族メチリデン化合物、それを製造するための化合物、それらの製造方法、及び芳香族メチリデン化合物を用いた有機電界発光素子
ATE409176T1 (de) * 2003-02-21 2008-10-15 Chiesi Farma Spa 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
ITMI20030311A1 (it) * 2003-02-21 2004-08-22 Chiesi Farma Spa Acidi 2-fenil-2-dialchil-acetici per il trattamento della malattia di alzheimer.
EP1650183A1 (en) * 2004-10-21 2006-04-26 Cellzome Ag (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy
US7524870B2 (en) * 2004-12-03 2009-04-28 Hoffmann-La Roche Inc. Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
WO2006133559A1 (en) * 2005-06-14 2006-12-21 Merck Frosst Canada Ltd. Reversible inhibitors of monoamine oxidase a and b
JP5272345B2 (ja) * 2006-08-28 2013-08-28 東ソー株式会社 ヘテロアセン誘導体、テトラハロターフェニル誘導体及びそれらの製造方法
CN102596879B (zh) * 2009-08-04 2015-01-28 奇斯药制品公司 制备1-(2-卤代联苯-4-基)-环丙烷羧酸的衍生物的方法

Also Published As

Publication number Publication date
MA32297B1 (fr) 2011-05-02
DK2285765T3 (da) 2012-06-04
EP2285765B1 (en) 2012-04-04
GEP20135800B (en) 2013-04-10
SI2285765T1 (sl) 2012-08-31
CN102046576B (zh) 2013-08-21
PT2285765E (pt) 2012-06-21
AU2009256959A1 (en) 2009-12-17
ZA201007977B (en) 2012-02-29
EP2285765A1 (en) 2011-02-23
NZ589087A (en) 2012-03-30
CA2723878C (en) 2016-06-28
BRPI0909560A2 (pt) 2015-09-22
HK1152292A1 (en) 2012-02-24
IL209209A (en) 2014-05-28
MY150280A (en) 2013-12-31
JP2011523953A (ja) 2011-08-25
KR101257217B1 (ko) 2013-04-22
UA101835C2 (uk) 2013-05-13
AU2009256959B2 (en) 2014-03-27
RU2010146299A (ru) 2012-07-20
MX2010012285A (es) 2010-12-01
EP2133322A1 (en) 2009-12-16
JP5642067B2 (ja) 2014-12-17
KR20110010633A (ko) 2011-02-01
CN102046576A (zh) 2011-05-04
ES2384368T3 (es) 2012-07-04
ATE552230T1 (de) 2012-04-15
US20090312426A1 (en) 2009-12-17
ME01160B (me) 2013-03-20
RU2502721C2 (ru) 2013-12-27
IL209209A0 (en) 2011-01-31
HRP20120517T1 (hr) 2012-07-31
PL2285765T3 (pl) 2012-08-31
US8076505B2 (en) 2011-12-13
CA2723878A1 (en) 2009-12-17
WO2009149797A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
CO6331461A2 (es) Proceso de preparacion de derivados del acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico
CY1118310T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων
PT2411396E (pt) Derivados de tienopirimidinadiona como moduladores de trpa1
PH12012500634A1 (en) Processes for preparing of glucopyranosyl -substituted benzyl -benzene derivatives
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
NI200900151A (es) Nuevo procedimiento de síntesis de la agomelatina.
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
TW200801027A (en) Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
NI200900153A (es) Nuevo procedimiento de síntesis de la agomelatina.
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
UA111868C2 (uk) Спосіб одержання естерів (5-фтор-2-метил-3-хінолін-2-ілметиліндол-1-іл)-оцтової кислоти
MY157304A (en) Process for the preparation of a compound useful as an inhibator of tafia
IN2014MN00971A (enExample)
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
NI200900152A (es) Nuevo procedimiento de síntesis de la agomelatina
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
CL2008003065A1 (es) Proceso para preparar un compuesto derivado de acido carbamoil-fosfonico o del acido carbamoil-fosfinico.
BR112012010486A2 (pt) processo para preparação de compostos 1-3 pirazol, processo para preparação de um acido pirazolcarboxilico da formula ia e processo para preparação de um composto da formula v
WO2010029457A3 (en) An improved process for preparing losartan potassium
MX2011009734A (es) Nuevo procedimiento de preparacion de compuestos de enaminocarbonilio.

Legal Events

Date Code Title Description
FG Application granted